Company Filing History:
Years Active: 2018
Title: James Wieler: Innovator in Cancer Detection Technologies
Introduction: James Wieler is a notable inventor based in Exeter, NH, whose work has significantly contributed to the field of cancer diagnostics. With a focus on enhancing detection methods, Wieler's innovations are pivotal in improving patient outcomes in oncology.
Latest Patents: Wieler holds one patent titled "Compositions and Methods for Detecting EGFR in Cancer." This invention discloses binding agents targeting the E746-A750 deletion and the L858R point mutations in the epidermal growth factor receptor (EGFR) molecule. His patent also elaborates on methods for utilizing these agents in both the diagnosis and treatment of cancer, underscoring their potential in transforming cancer care.
Career Highlights: Currently, James Wieler is affiliated with Cell Signaling Technology, Inc., a company known for its contributions to research and development in cell signaling and cancer biology. His work aligns with the company's mission to deliver effective tools for cancer research, making significant strides in the field.
Collaborations: Throughout his career, Wieler has collaborated with esteemed coworkers, including Ting-Lei Gu and Jiong Wu. Their joint efforts reflect a strong commitment to advancing research and technology in cancer detection, fostering innovation within their field.
Conclusion: James Wieler exemplifies the spirit of innovation in the realm of cancer diagnostics. With a keen focus on the epidermal growth factor receptor and its implications in cancer, his contributions are invaluable. Through his patent and work at Cell Signaling Technology, Inc., Wieler continues to push the boundaries of what is possible in medical research and treatment.